Positive trends in all market regions and product groups

11-May-2022

During fiscal year 2021, the globally positioned Eppendorf Group saw its consolidated revenue climb to €1.1 billion (prior year: €967.2 million), amounting to an increase of 13.8% (prior year: 20.3%). Operating profit also rose significantly in 2021, reaching €272 million (prior year: €217.7 ...

more

Global political and economic uncertainties substantially increased

22-Apr-2022

Sartorius recorded a dynamic start to fiscal 2022, with sales revenue and earnings posting strong double-digit growth rates in the first quarter compared with the prior-year period. Based on its performance in the first three months, Sartorius confirms its outlook for fiscal 2022. “Sartorius had ...

more

Startup expands its management team and board of directors with the addition of several industry veterans

22-Feb-2022

ONI, a biotechnology company democratizing the ability to observe single molecules in living cells with its desktop Nanoimager microscopy platform, announced the closing of a $75 million Series B financing. The round was led by ARCH Venture Partners and Casdin Capital, with participation from ...

more

Identify diseases while you wait: Technology aims to improve speed, cost and accuracy of infectious disease diagnostics

18-Feb-2022

OxDX, a University of Oxford spin out building instant pathogen tests using super-resolution microscopy and machine learning,has raised £2.6m in pre-seed funding for its AI powered diagnostic technology that can recognise and identify specific species and strains of viruses1,2, bacteria and other ...

more

Heightened demand from all corners of the globe

10-Feb-2022

INTEGRA Biosciences has enjoyed considerable growth for more than 10 years – averaging 18 percent per annum – and more than doubling in the previous two years. In 2020, we grew by 73 percent, and this was followed by a 46 percent increase in turnover in 2021, reaching 191 million Swiss Francs. In ...

more

Number of employees rises by 30 percent to nearly 14,000

27-Jan-2022

Due to the excellent development of its core business, additional demand generated by the coronavirus pandemic, and several acquisitions, the life science group Sartorius closed fiscal 2021 with exceptionally strong growth and a jump in profitability. According to preliminary figures, the company ...

more

Dermagnostix closes seven-figure seed round

17-Dec-2021

Dermagnostix revolutionizes diagnostics in dermatology with its fully auto-mated "lab-in-a-box" system, which allows the technically valid performance of complex molecular assays. "Modern molecular diagnostics is a prerequisite for implementing precision medicine in dermatology. It not only ...

more

In fiscal year 2020/21, ZEISS achieves highest revenue yet in its 175-year history at 7.5 billion euros

16-Dec-2021

The ZEISS Group ended fiscal year 2020/21 (end of reporting period: 30 September 2021) on an excellent note: its revenue rose by 20% to 7.529 billion euros (previous year: 6.297 billion euros). Over 90% of this sum was generated in markets outside Germany. Earnings before interest and tax (EBIT) ...

more

Major investments are expanding manufacturing capacity for life sciences products at 13 Cytiva and Pall Corporation sites helping to meet customer demand.

03-Aug-2021

An ongoing strategic growth plan from Cytiva and Pall Corporation, part of the Danaher Corporation, will expand manufacturing capacity and services across geographies for global life sciences customers. The investment, already underway, includes new sites, expansion at existing factories, and is ...

more

Significant double-digit increases in sales and earnings

22-Jul-2021

Sartorius has continued on its fast growth trajectory, closing the first half of 2021 with significant double-digit increases in both sales revenue and order intake. “In the first six months of the year, we have seen unabated high demand for innovative technologies used in the development and ...

more